Tema de Pesquisa

Metabolic Health

Insulin resistance, blood sugar regulation, metabolic syndrome, and body composition

417 artigos

Vias de Biossíntese do NAD+: As Três Rotas para a Moeda Energética Celular
Metabolic Health
Premium

Vias de Biossíntese do NAD+: As Três Rotas para a Moeda Energética Celular

Domine as vias de salvamento, de novo e de Preiss-Handler que mantêm os níveis de NAD+ e impulsionam as intervenções de longevidade.

TutorialAvançado
9 de abr. de 2026 0
NAD+: A Moeda Energética das Suas Células e Por Que Ela Diminui com a Idade
Metabolic Health
Premium

NAD+: A Moeda Energética das Suas Células e Por Que Ela Diminui com a Idade

Descubra como o NAD+ alimenta suas células e por que essa molécula crucial diminui com o envelhecimento, além de formas práticas de manter níveis saudáveis.

TutorialIniciante
9 de abr. de 2026 0
TyG Index Plus Obesity Measures Better Predict Heart Disease Risk Over Time
Metabolic Health

TyG Index Plus Obesity Measures Better Predict Heart Disease Risk Over Time

8-year study of 3,505 Chinese adults shows combining triglyceride-glucose index with waist circumference best predicts cardiovascular disease.

Artigo Científico
9 de abr. de 2026 0
Higher Insulin Sensitivity Linked to 30% Lower Death Risk in Fatty Liver Disease
Metabolic Health

Higher Insulin Sensitivity Linked to 30% Lower Death Risk in Fatty Liver Disease

Large study of 6,847 patients shows better glucose disposal rates significantly reduce mortality risk in metabolic liver disease.

Artigo Científico
9 de abr. de 2026 0
Blood Sugar Stress Ratio Predicts Chronic Disease Risk in Middle-Aged Adults
Metabolic Health

Blood Sugar Stress Ratio Predicts Chronic Disease Risk in Middle-Aged Adults

New biomarker identifies who's at highest risk for diabetes, hypertension, and liver disease using simple blood test calculations.

Artigo Científico
9 de abr. de 2026 0
SGLT2 Inhibitor Dapagliflozin Reshapes Metabolism Beyond Blood Sugar Control
Metabolic Health

SGLT2 Inhibitor Dapagliflozin Reshapes Metabolism Beyond Blood Sugar Control

New study reveals how the diabetes drug dapagliflozin dramatically alters fat metabolism and kidney function through previously unknown pathways.

Artigo Científico
9 de abr. de 2026 0
Melatonin Reverses Metabolic Damage in IVF Children by Fixing Liver Enzymes
Metabolic Health

Melatonin Reverses Metabolic Damage in IVF Children by Fixing Liver Enzymes

New research shows melatonin supplementation during IVF can prevent obesity and glucose problems in offspring by restoring liver function.

Artigo Científico
9 de abr. de 2026 0
GLP-1 Drugs Transform Diabetes Treatment with Weight Loss and Heart Benefits
Metabolic Health

GLP-1 Drugs Transform Diabetes Treatment with Weight Loss and Heart Benefits

Review explores how GLP-1 receptor agonists revolutionize type 2 diabetes care through improved blood sugar control and significant weight reduction.

Artigo Científico
9 de abr. de 2026 0
New Weight Loss Drug Mazdutide Shows 14% Weight Reduction in Chinese Adults
Metabolic Health

New Weight Loss Drug Mazdutide Shows 14% Weight Reduction in Chinese Adults

Phase 3 trial shows once-weekly mazdutide injections led to significant weight loss with minimal side effects in overweight Chinese adults.

Artigo Científico
9 de abr. de 2026 0
Propionate Protects Diabetic Liver from High-Fat Diet Damage in New Study
Metabolic Health

Propionate Protects Diabetic Liver from High-Fat Diet Damage in New Study

Sodium propionate reduced liver inflammation and fat accumulation in diabetic mice fed high-fat, AGE-rich diets through multiple protective mechanisms.

Artigo Científico
9 de abr. de 2026 0
GLP-1 Receptor Agonists Show Promise for Longevity and Metabolic Health
Metabolic Health

GLP-1 Receptor Agonists Show Promise for Longevity and Metabolic Health

New England Journal review explores the expanding therapeutic potential of GLP-1 drugs beyond diabetes treatment.

Artigo Científico
9 de abr. de 2026 0
Genetic Variants Explain Why Obesity Drugs Work Better for Some People
Metabolic Health

Genetic Variants Explain Why Obesity Drugs Work Better for Some People

New research reveals genetic factors that determine individual responses to weight-loss medications like semaglutide.

Artigo Científico
9 de abr. de 2026 0
AnteriorPágina 14 de 35Próximo